Monday, May 21, 2018
 
 
Company News: Page (1) of 1 - 04/26/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Global Life Sciences Commercialization Services Platform Brings Combined Expertise to Asembia Specialty Pharmacy Summit
 
(April 26, 2018)

CHICAGO and NEW YORK, April 26, 2018 /PRNewswire/ -- The industry's fastest growing life science commercialization services platform will showcase its collective expertise at the Asembia Specialty Pharmacy Summit in Las Vegas, Nev., April 29May 2.

The platform, in partnership with Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry, and JLL Partners, a leading middle-market private equity firm, has grown to become the industry's leading independent provider of end-to-end commercialization services to help innovators and established pharmaceutical companies maximize the impact of new therapies.

After a series of recent acquisitions and partnerships, the platform includes the industry's leading service providers including Dohmen Life Science Services, The Access Group, Alliance Life Sciences, Health Strategies Group, Triplefin and Patient Experience Project. Together under one platform, these businesses provide clients with a comprehensive portfolio of solutions, including channel, market access, patient support and compliance services.



"We are creating something our industry desperately needs – a new way to address the shift to patient-centric healthcare," said Jim Lang, executive chairman of the platform. "Therapies are becoming more complex and constituents — regulators, payers, providers, channel partners and patients – are demanding more.  The era of value-based, patient-centered solutions has come, and we aspire to be the industry's partner of choice."

As one entity, the newly expanded platform employs more than 1,500 global professionals who will serve more than 300 of the industry's top biopharmaceutical and medical device companies.  Platform representatives will be available at booth 219, along with a Dohmen Life Science Services exhibit 216 and Triplefin exhibit 100.

 

Cision View original content:http://www.prnewswire.com/news-releases/global-life-sciences-commercialization-services-platform-brings-combined-expertise-to-asembia-specialty-pharmacy-summit-300637299.html

SOURCE Water Street Healthcare Partners

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Science,Medical,Science,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis
  • Regenerative Medicine Market Analysis Study Found Huge Boom By Rising Prevalence Of Chronic Diseases And Genetic Disorders Till 2025: Grand View Research,Inc.
  • Global Molecular Diagnostics Markets, 2016-2024 - Focus on Infectious Disease Testing, Blood Screening, Cancer Screening & Other Applications
  • Global Sleep Apnea Diagnostic and Therapeutic Devices Strategic Business Report 2018
  • Global Sleep Apnea Diagnostic and Therapeutic Devices: 2016/18-2024 Strategic Business Analysis & Forecast Report - mHealth-Enabled Sleep Tracking Devices Gain Ground

    Cancer
  • Oasmia Pharmaceutical Completes Spin-off of Veterinary Oncology Assets to Wholly Owned US Subsidiary, AdvaVet, Inc.
  • Altogen Labs xenograft services for drug development studies of anti-cancer therapeutics
  • HedgePath Pharmaceuticals Announces Additional Expanded Patent Coverage
  • Dr. Haydee Gonzalez Hidalgo joins The Oncology Institute of Hope and Innovation
  • eClinical Solutions Market Size Is Projected To Reach $13 Billion By 2024
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines